Literature DB >> 17164975

Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme.

Ramon Martinez, Gabriele Schackert, Ricard Yaya-Tur, Iñigo Rojas-Marcos, James G Herman, Manel Esteller.   

Abstract

We have performed a methylation-specific PCR approach to comparatively analyze the MGMT promoter methylation status in 186 glioblastomas (GBM) from patients with classic survival and nine from patients with long-term survival (LTS GBM). The methylation rate in LTS GBM was significantly higher (77.8% vs. 39.2%, P = 0.033) which suggests that MGMT hypermethylation is a frequent hallmark of LTS GBM and contributes to characterize this intriguing GBM subtype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17164975     DOI: 10.1007/s11060-006-9292-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  3 in total

1.  Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

Authors:  M Esteller; J Garcia-Foncillas; E Andion; S N Goodman; O F Hidalgo; V Vanaclocha; S B Baylin; J G Herman
Journal:  N Engl J Med       Date:  2000-11-09       Impact factor: 91.245

2.  MGMT gene silencing and benefit from temozolomide in glioblastoma.

Authors:  Monika E Hegi; Annie-Claire Diserens; Thierry Gorlia; Marie-France Hamou; Nicolas de Tribolet; Michael Weller; Johan M Kros; Johannes A Hainfellner; Warren Mason; Luigi Mariani; Jacoline E C Bromberg; Peter Hau; René O Mirimanoff; J Gregory Cairncross; Robert C Janzer; Roger Stupp
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

Review 3.  Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer.

Authors:  Manel Esteller; James G Herman
Journal:  Oncogene       Date:  2004-01-08       Impact factor: 9.867

  3 in total
  42 in total

Review 1.  Large cystic glioblastoma multiforme.

Authors:  C-Y Choi; G-T Yee; C-H Lee; M Joo
Journal:  Clin Neuroradiol       Date:  2013-06       Impact factor: 3.649

2.  Primer extension based quantitative polymerase chain reaction reveals consistent differences in the methylation status of the MGMT promoter in diffusely infiltrating gliomas (WHO grade II-IV) of adults.

Authors:  Erik Vassella; Istvan Vajtai; Nora Bandi; Marlene Arnold; Verena Kocher; Luigi Mariani
Journal:  J Neurooncol       Date:  2010-12-22       Impact factor: 4.130

3.  Computationally simple analysis of matched, outcome-based studies of ordinal disease states.

Authors:  Rebecca A Betensky; Jackie Szymonifka; Eudocia Q Lee; Catherine L Nutt; Tracy T Batchelor
Journal:  Stat Med       Date:  2015-04-22       Impact factor: 2.373

4.  "MGMT for pt mgmt": is methylguanine-DNA methyltransferase testing ready for patient management?

Authors:  A John Iafrate; David N Louis
Journal:  J Mol Diagn       Date:  2008-06-13       Impact factor: 5.568

5.  Differential molecular genetic analysis in glioblastoma multiforme of long- and short-term survivors: a clinical study in Chinese patients.

Authors:  Guo-Bin Zhang; Xiang-Li Cui; Da-Li Sui; Xiao-Hui Ren; Zhe Zhang; Zhong-Cheng Wang; Song Lin
Journal:  J Neurooncol       Date:  2013-03-15       Impact factor: 4.130

6.  Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival.

Authors:  Yanhong Liu; Sanjay Shete; Carol J Etzel; Michael Scheurer; George Alexiou; Georgina Armstrong; Spyros Tsavachidis; Fu-Wen Liang; Mark Gilbert; Ken Aldape; Terri Armstrong; Richard Houlston; Fay Hosking; Lindsay Robertson; Yuanyuan Xiao; John Wiencke; Margaret Wrensch; Ulrika Andersson; Beatrice S Melin; Melissa Bondy
Journal:  J Clin Oncol       Date:  2010-04-05       Impact factor: 44.544

Review 7.  O(6)-methylguanine-DNA methyltransferase in glioma therapy: promise and problems.

Authors:  John R Silber; Michael S Bobola; A Blank; Marc C Chamberlain
Journal:  Biochim Biophys Acta       Date:  2012-01-08

Review 8.  Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers.

Authors:  Michael Jansen; Stephen Yip; David N Louis
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

9.  NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells.

Authors:  Xuan Wang; Lili Jia; Xiaohua Jin; Qian Liu; Wei Cao; Xiangdong Gao; Mingfeng Yang; Baoliang Sun
Journal:  Oncol Lett       Date:  2015-04-21       Impact factor: 2.967

10.  Glioblastoma Multiforme Oncogenomics and Signaling Pathways.

Authors:  Okezie O Kanu; Betsy Hughes; Chunhui Di; Ningjing Lin; Jinrong Fu; Darell D Bigner; Hai Yan; Cory Adamson
Journal:  Clin Med Oncol       Date:  2009-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.